Lexaria Bioscience Corp
Officers & Directors
Richard Christopher Chief Executive Officer - (Principal Executive Officer) Dr. Catherine C. Turkel Director William Edward (Ted) McKechnie Director Albert Reese Jr. Director Nicholas Baxter Director Michael Shankman Chief Financial Officer - (Principal Financial Officer) ,
Lexaria Bioscience Corp currently has 27 employees.
News about Lexaria Bioscience Corp Key Personnel |
as Profitable: Lexaria Bioscience s Breakthrough Drug-Delivery System Revolutionizes Medical Treatments
Lexaria Bioscience Corp. (NASDAQ: LEXX) has recently revealed its groundbreaking proprietary drug-delivery system, which has the potential to revolutionize the way molecules enter the bloodstream and offer exciting new possibilities for GLP-1 Diabetes and weight-loss drugs. With this innovative technology, the company aims to address some of the most significant challenges in the pharmaceutical industry and open doors for revolutionary cures.
In the fourth quarter of 2023, Lexaria Bioscience Corp reported a cumulative net loss of $-8 million, resulting in a negative return on equity (ROE) of -195....
|
Lexaria Bioscience Corp. (NASDAQ: LEXX) has recently announced an exciting breakthrough in drug delivery technology, elevating the efficacy and delivery of GLP-1 agonists through its proprietary platform. The company s achievements have been highlighted in an editorial published by NetworkNewsWire, a leading financial news and content distribution platform.
The innovative drug-delivery platform developed by Lexaria Bioscience Corp. has the potential to revolutionize the administration of GLP-1 agonists, a class of drugs used in the treatment of type 2 diabetes. By enhancing the delivery of these medications, the company aims to improve patient outcomes and offer a more convenient and effective solution f...
|
|
